Literature DB >> 18805030

Equine herpesvirus-1 myeloencephalopathy: a review of recent developments.

Nicola Pusterla1, W David Wilson, John E Madigan, Gregory L Ferraro.   

Abstract

Equine herpes myeloencephalopathy (EHM), although a relatively uncommon manifestation of equine herpesvirus-1 (EHV-1) infection, can cause devastating losses on individual farms or boarding stables. Although outbreaks of EHM have been recognized for centuries in domestic horse populations, many aspects of this disease remained poorly characterized. In recent years, an improved understanding of EHM has emerged from experimental studies and from data collected during field outbreaks at riding schools, racetracks and veterinary hospitals throughout North America and Europe. These outbreaks have highlighted the contagious nature of EHV-1 and have prompted a re-evaluation of diagnostic procedures, treatment modalities, preventative measures and biosecurity protocols for the disease. This review concentrates on these and other selected, clinically relevant aspects of EHM.

Entities:  

Mesh:

Year:  2008        PMID: 18805030     DOI: 10.1016/j.tvjl.2008.08.004

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  13 in total

1.  An Equine Herpesvirus Type 1 (EHV-1) Ab4 Open Reading Frame 2 Deletion Mutant Provides Immunity and Protection from EHV-1 Infection and Disease.

Authors:  Christiane L Schnabel; Susanna Babasyan; Alicia Rollins; Heather Freer; Christine L Wimer; Gillian A Perkins; Fahad Raza; Nikolaus Osterrieder; Bettina Wagner
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Role of equine herpesviruses as co-infecting agents in cases of abortion, placental disease and neonatal foal mortality.

Authors:  Maria Luisa Marenzoni; Annalisa Bietta; Elvio Lepri; Patrizia Casagrande Proietti; Paolo Cordioli; Elena Canelli; Valentina Stefanetti; Mauro Coletti; Peter J Timoney; Fabrizio Passamonti
Journal:  Vet Res Commun       Date:  2013-09-20       Impact factor: 2.459

3.  Equine herpesvirus-1, non-neurogenic pathotype, in a 9-year-old American Saddlebred with neurological signs.

Authors:  Tammy M-J Heerkens
Journal:  Can Vet J       Date:  2009-03       Impact factor: 1.008

4.  A trypsin-like serine protease is involved in pseudorabies virus invasion through the basement membrane barrier of porcine nasal respiratory mucosa.

Authors:  Sarah Glorieux; Herman W Favoreel; Lennert Steukers; Annelies P Vandekerckhove; Hans J Nauwynck
Journal:  Vet Res       Date:  2011-04-14       Impact factor: 3.683

5.  Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission.

Authors:  Bart Spiesschaert; Nikolaus Osterrieder; Walid Azab
Journal:  Viruses       Date:  2015-02-03       Impact factor: 5.048

6.  Genetic characterization of equid herpesvirus type 1 from cases of abortion in Poland.

Authors:  Karol Stasiak; Magdalena Dunowska; Simon F Hills; Jerzy Rola
Journal:  Arch Virol       Date:  2017-04-27       Impact factor: 2.574

7.  CCL2 and CCL5 driven attraction of CD172a+ monocytic cells during an equine herpesvirus type 1 (EHV-1) infection in equine nasal mucosa and the impact of two migration inhibitors, rosiglitazone (RSG) and quinacrine (QC).

Authors:  Jing Zhao; Katrien C K Poelaert; Jolien Van Cleemput; Hans J Nauwynck
Journal:  Vet Res       Date:  2017-02-27       Impact factor: 3.683

8.  Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro.

Authors:  Rebecca L Tallmadge; Emilija Žygelytė; Gerlinde R Van de Walle; Thomas M Kristie; M Julia B Felippe
Journal:  Front Vet Sci       Date:  2018-03-12

9.  Clinical observations and management of a severe equine herpesvirus type 1 outbreak with abortion and encephalomyelitis.

Authors:  Jasmin Walter; Christoph Seeh; Kerstin Fey; Ulrich Bleul; Nikolaus Osterrieder
Journal:  Acta Vet Scand       Date:  2013-03-05       Impact factor: 1.695

10.  Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense.

Authors:  Katrien C K Poelaert; Jolien Van Cleemput; Kathlyn Laval; Herman W Favoreel; Gisela Soboll Hussey; Roger K Maes; Hans J Nauwynck
Journal:  Front Cell Infect Microbiol       Date:  2018-09-12       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.